TABLE 4.
Evaluation of acute toxicity in mice treated with pYR, cpYR, or neomycin sulfate (positive control)
| Dose (mg · kg−1) and effecta | No. of mice (n = 5/group) |
||
|---|---|---|---|
| Neomycin sulfate | pYR | cpYR | |
| 0 | |||
| No effect | 5 | 5 | 5 |
| Toxicity level I | 0 | 0 | 0 |
| Toxicity level II | 0 | 0 | 0 |
| 5 | |||
| No effect | 5 | 5 | 5 |
| Toxicity level I | 0 | 0 | 0 |
| Toxicity level II | 0 | 0 | 0 |
| 10 | |||
| No effect | 5 | 5 | 5 |
| Toxicity level I | 0 | 0 | 0 |
| Toxicity level II | 0 | 0 | 0 |
| 25 | |||
| No effect | 3 | 4 | 5 |
| Toxicity level I | 2 | 1 | 0 |
| Toxicity level II | 0 | 0 | 0 |
| 50 | |||
| No effect | 2 | 2 | 4 |
| Toxicity level I | 0 | 2 | 1 |
| Toxicity level II | 3 | 1 | 0 |
| 100 | |||
| No effect | 2 | 1 | 3 |
| Toxicity level I | 0 | 2 | 2 |
| Toxicity level II | 3 | 2 | 0 |
Toxicity grading was as follows: level I, narrowing of eyes; level II, crouching and cuddling.